APA (7th ed.) Citation

QB, L., HT, S., K, Z., JB, S., XY, M., G, C., . . . HJ, S. (2025). Therapeutic Targeting of Decr1 Ameliorates Cardiomyopathy by Suppressing Mitochondrial Fatty Acid Oxidation in Diabetic Mice. Journal of cachexia, sarcopenia and muscle, 16(2), e13761. https://doi.org/10.1002/jcsm.13761

Chicago Style (17th ed.) Citation

QB, Lu, et al. "Therapeutic Targeting of Decr1 Ameliorates Cardiomyopathy by Suppressing Mitochondrial Fatty Acid Oxidation in Diabetic Mice." Journal of Cachexia, Sarcopenia and Muscle 16, no. 2 (2025): e13761. https://doi.org/10.1002/jcsm.13761.

MLA (9th ed.) Citation

QB, Lu, et al. "Therapeutic Targeting of Decr1 Ameliorates Cardiomyopathy by Suppressing Mitochondrial Fatty Acid Oxidation in Diabetic Mice." Journal of Cachexia, Sarcopenia and Muscle, vol. 16, no. 2, 2025, p. e13761, https://doi.org/10.1002/jcsm.13761.